Overview
HIV-1 is the predominant type of human immunodeficiency virus and is responsible for the majority of HIV infections and the global AIDS pandemic. A lentivirus of the retrovirus family, it carries a single-stranded RNA genome and the enzymes reverse transcriptase, integrase, and protease, which mediate conversion of viral RNA to DNA, integration into the host genome, and maturation of new virions; these enzymes are also principal targets of antiretroviral drugs. HIV-1 enters CD4-positive T cells and macrophages via the CD4 receptor and chemokine co-receptors, and its high replication and mutation rates underlie immune evasion, drug resistance, and substantial genetic diversity among groups and subtypes. Transmission occurs through sexual contact, blood, and from mother to child, and progressive depletion of CD4 cells leads to immunodeficiency. Research spans molecular targets, immune responses, and therapeutic and preventive strategies. The subject matter examined in this area includes HLA-E-restricted HIV-1-specific immune responses and T-cell vaccination, docking studies of HIV-1 reverse transcriptase and protease with plant-derived compounds, immunological effects of phytochemical consumption in HIV-1-seropositive individuals, the proposal that phytochemicals may arrest HIV-1 progression, antioxidant capacity and CD4 counts in treated patients, and adherence to pre-exposure prophylaxis. The journal publishes peer-reviewed research on HIV-1 virology, immunology, and clinical management.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Docking Studies of HIV-1 Reverse Transcriptase and HIV-1 Protease with Phytocompounds of Carissa Carandas L.
Clinical and Immunological Beneficial Effects of Phyto V7 Consumption by HIV-1 Seropositive Individuals
Phytochemicals May Arrest HIV-1 Progression
Painful Lesions in an HIV-1 Seropositive African Woman.
Characterization of People Receiving 2-Drug Regimens (2DR) for HIV Management in Italy
Syphilis and Beyond: A Comprehensive Analysis of Associated Infections and Comorbidities in a Five-Year Retrospective Study in the United Arab Emirates (2018-2022)
Exploring HIV Self-Testing: Barriers and Facilitators among Undergraduate Students
Predictors of Adherence to Pre-Exposure Prophylaxis among Female Sex Workers in South-Western Nigeria
Differential of Antioxidant Ability, CD4+T Cells Count and Viral Load in HIV Infected Patients on cART in Yaounde, Cameroon
Risk Factors of HIV among Voluntary Counseling and Testing Centers Clients, Elgenina Town, West Darfur, Sudan.
How this research is being cited
The 12 articles above have been cited 18 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · BMC Public Health
-
2025 · The Natural Products Journal
-
2024 · World Journal of Advanced Research and Reviews
-
2024 · Journal of Microbiology & Experimentation
-
2024 · Journal of Microbiology & Experimentation
-
2024 · Heliyon
-
2024 · Heliyon
-
F. Bongomin et al. · 2023 · Therapeutic Advances in Infectious Disease
A sample of recent works citing this journal's research on Hiv-1, linking to each citing work.